Remove Bacteria Remove Contamination Remove Gene Therapy Remove Production
article thumbnail

Guide to using AAV vectors in gene therapy

Drug Discovery World

In 2023, DDW hosted a webinar, ‘A comprehensive guide to using adeno-associated virus (AAV) vectors in gene therapy’, supported by Azenta Life Sciences. AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers. Why are those important?

article thumbnail

Guide to using AAV vectors in gene therapy

Drug Discovery World

Earlier this year, DDW hosted a webinar, ‘A comprehensive guide to using adeno-associated virus (AAV) vectors in gene therapy’, supported by Azenta Life Sciences. AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Cell culture Q&A: Solving biomanufacturing challenges with Recombinant Insulin supplementation

Pharmaceutical Technology

In this Q&A, Pharmaceutical Technology speaks to Sara Bursomanno, PhD Global Product Manager, Novo Nordisk Pharmatech, on insulin’s role in the past, present, and future of cell culture processes. One big challenge is contamination. At the same time, biopharmas also have to keep up with the high demand for their drug products.

Insulin 130
article thumbnail

Improving quality control for CAR T cell therapies

Drug Discovery World

By Mark White, Associate Director of Biopharma Product Marketing at Bio-Rad and Marwan Alsarraj, Biopharma Segment Manager, Digital Biology Group. The discovery of CART cell therapy resulted from decades of research dedicated to understanding the immune system and its role in treating cancer. Detecting replication-competent viruses.